Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions. 

To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Company Growth (employees)
Type
Public
HQ
Jersey, JE
Founded
1986
Size (employees)
23,906 (est)
Website
shire.com
Shire was founded in 1986 and is headquartered in Jersey, JE

Key People at Shire

Graham Hetherington

Graham Hetherington

Chief Financial Officer
William Burns

William Burns

Non-Executive Director
Susan Kilsby

Susan Kilsby

Non-Executive Director
Steven Gillis

Steven Gillis

Non-Executive Director
David Kappler

David Kappler

Deputy Chairman

Shire Office Locations

Shire has offices in Jersey, Dublin, Lexington, Zug and in 37 other locations
Jersey, JE (HQ)
No. 99854, 22 Grenville Street, St Helier
Singapore, SG
3 Science Park Drive, #02-02/03 The Franklin, Singapore Science Park 1
Mexico City, MX
Av. Paseo de los Tamarindos 90, Torre 1, Piso 7, Col. Bosques de las Lomas, Del. Cuajimalpa
Tokyo, JP
Shinjuku Front Tower, 29th Floor, 2-21-1 Kita-Shinjuku, Shinjuku-ku
Berlin, DE
Friedrichstraße 149
Boulogne Billancourt, FR
88, rue du Dôme
Show all (41)

Shire Data and Metrics

Shire Financial Metrics

Shire's revenue was reported to be $3.6 b in Q1, 2017
USD

Revenue (Q1, 2017)

3.6 b

Gross profit (Q1, 2017)

2.2 b

Gross profit margin (Q1, 2017), %

63%

Net income (Q1, 2017)

375 m

Market capitalization (25-Jul-2017)

49.5 b

Closing share price (25-Jul-2017)

163.6

Cash (31-Mar-2017)

369 m
Shire's current market capitalization is $49.5 b.
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

122.3 m6 b6.4 b11.4 b

Revenue growth, %

4824%7%78%

Cost of goods sold

979.3 m969 m3.8 b

Gross profit

5 b5.4 b7.6 b

Gross profit Margin, %

84%85%67%

R&D expense

1.1 b1.6 b1.4 b

General and administrative expense

1.8 b1.8 b3 b

Operating expense total

4.3 b5 b10.4 b

EBIT

1.7 b1.4 b962.9 m

EBIT margin, %

28%22%8%

Interest expense

30.8 m41.6 m469.6 m

Interest income

24.7 m4.2 m18.4 m

Pre tax profit

626 k3.3 b1.4 b486.1 m

Income tax expense

(56.1 m)(46.1 m)126.1 m

Net Income

1.6 m3.4 b1.3 b327.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

1.6 b1.7 b1.7 b2.4 b3.5 b3.6 b

Cost of goods sold

228 m262.7 m248.6 m778.1 m1.7 b1.3 b

Gross profit

1.3 b1.4 b1.5 b1.7 b1.7 b2.2 b

Gross profit Margin, %

85%84%85%68%50%63%

R&D expense

775.9 m241.2 m217.1 m294.8 m511.1 m379.3 m

General and administrative expense

627.3 m575 m609.5 m675.3 m875.6 m888.9 m

Operating expense total

1.4 b816.2 m826.6 m970.1 m1.4 b1.3 b

Interest expense

(11.3 m)(10.7 m)(44.7 m)(87.2 m)(186.9 m)(142.3 m)

Interest income

600 k800 k1 m1.6 m9.3 m3.1 m

Income tax expense

44.1 m22.3 m(82.1 m)229.6 m(6.8 m)

Net Income

753.5 m1.2 b410.4 m570 m1 b419 m375 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash

528.8 m

Accounts Receivable

2.6 b

Inventories

455.3 m544.8 m635.4 m3.6 b

Current Assets

156.6 m151.6 m158.9 m7.5 b

PP&E

37 m26.9 m22.9 m

Goodwill

225 k166 k107 k17.9 b

Total Assets

193.9 m178.7 m181.9 m67 b

Accounts Payable

1.8 m424 k486 k4.3 b

Total Debt

1.6 b19.9 b

Current Liabilities

23.6 m13 m12.1 m7.7 b

Total Liabilities

26.9 m13.2 m12.2 m38.1 b

Additional Paid-in Capital

4.2 b4.3 b4.5 b24.7 b

Retained Earnings

1.6 m(2.9 m)2.9 m5.9 b

Total Equity

167 m165.4 m169.8 m28.9 b

Debt to Equity Ratio

9.3 x0.7 x

Debt to Assets Ratio

8.7 x0.3 x

Financial Leverage

1.2 x1.1 x1.1 x2.3 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

153.6 m467.7 m74.3 m64 m44.9 m69 m693.4 m728.6 m369 m

Accounts Receivable

1.1 b1.1 b1.1 b1.1 b1.3 b1.3 b2.4 b2.6 b2.6 b

Inventories

585 m548.9 m588.7 m632.8 m608.9 m680 m5.8 b4.9 b3.3 b

Current Assets

2.6 b2.9 b2.5 b2.5 b2.7 b2.4 b9.7 b8.9 b7.1 b

PP&E

852.5 m845.6 m821.9 m816.7 m795.9 m837.6 m6.6 b6.5 b6.5 b

Goodwill

2.3 b2.4 b4.2 b4.2 b4.3 b6.9 b13 b14.9 b19.1 b

Total Assets

11.3 b11.5 b17.7 b17 b17.5 b24.1 b70.7 b69.8 b66.2 b

Accounts Payable

1.8 b1.7 b2 b1.9 b2 b2 b3.7 b4 b3.6 b

Current Liabilities

2.2 b2 b4.9 b4.3 b4.3 b4.3 b6.9 b7.1 b7 b

Additional Paid-in Capital

4.3 b4.3 b4.4 b4.4 b4.4 b4.5 b24.5 b24.6 b24.9 b

Retained Earnings

2 b2.5 b5 b5.1 b5.5 b6.2 b5.9 b5.5 b6.3 b

Total Equity

6.1 b6.5 b9 b9.1 b9.6 b10.3 b29.8 b29.8 b29.7 b

Financial Leverage

1.9 x1.8 x2 x1.9 x1.8 x2.3 x2.4 x2.3 x2.2 x
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

665.1 m3.4 b1.3 b327.4 m

Depreciation and Amortization

324.4 m407.3 m637.2 m1.5 b

Accounts Receivable

(210 m)(701.7 m)

Cash From Operating Activities

2.7 b

Purchases of PP&E

(157 m)

Cash From Investing Activities

(360.9 m)(4 b)(5.6 b)(18.1 b)

Cash From Financing Activities

15.8 b

Interest Paid

(29.9 m)(14.5 m)(20 m)(284 m)

Income Taxes Paid

947 k2.9 m(2.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

753.5 m1.2 b410.4 m570 m1 b419 m375 m

Depreciation and Amortization

204.8 m307.1 m120.6 m291.8 m457.4 m168.9 m429.8 m877.8 m486.9 m

Accounts Receivable

(37.3 m)(92.1 m)(85.1 m)(84.9 m)(288.1 m)(100.9 m)(181 m)(411.2 m)(35.3 m)

Cash From Operating Activities

1.1 b1.7 b561.6 m1 b1.6 b389.5 m980.4 m1.5 b459.1 m

Purchases of PP&E

(19.1 m)(49.8 m)

Cash From Investing Activities

(3.9 b)(4 b)(5.2 b)(5.2 b)(5.6 b)(5.7 b)(17.6 b)(17.8 b)(219.8 m)

Cash From Financing Activities

773.3 m567.2 m1.7 b1.3 b1.1 b5.2 b17.2 b16.9 b(401.8 m)

Interest Paid

(7.7 m)(5 m)(9.9 m)(13.9 m)(111.4 m)223.4 m108.2 m

Income Taxes Paid

(65.2 m)(97.5 m)355.8 m
USDY, 2017

Revenue/Employee

149.4 k

Financial Leverage

2.2 x

Shire Operating Metrics

FY, 2014FY, 2015FY, 2016

Countries

6872100

Projects in R&D Pipeline

272937

Phase II Trials

11610

Phase III Trials

71417

Phase Approved

234

Phase I Trials

766

Phase Preclinical

35

    Shire Market Value History

    Shire Revenue Breakdown

    Shire Median Salaries

    Source: 25 public H-1B filings from Shire

    Traffic Overview of Shire

    Shire Online and Social Media Presence

    Shire News and Updates

    Sports Direct knew nothing of "possible" camera at happy Shirebrook

    Sports Direct's share price plummeted over three per cent after responding to the sensational allegations from MPs that its staff spied on a private meeting of MPs from the business select committee. "The Board would like to make it clear that it did not authorise or have any knowledge of the pos…

    Sports Direct's Shirebrook warehouse gets surprise MPs visit

    MPs from the Business and Skills Committee make a surprise visit to Sports Direct's controversial Shirebrook warehouse.

    Six MPs make surprise visit to Sports Direct's Shirebrook warehouse

    Business select committee members tour site after company was accused in July of running business like Victorian workhouseSix MPs behind the scathing report into working practices at Sports Direct have turned up at the retailer’s Shirebrook warehouse for a surprise inspection.Iain Wright, chairman o…

    MPs pay surprise visit to Sports Direct's Shirebrook warehouse

    MPs have made a surprise visit to Sports Direct's Shirebrook warehouse to take a look at how the retailer is progressing with improvements to its working practices. The Telegraph has reported that Iain Wright MP, chair of the business, energy and industrial strategy committee, which led an inquir…
    Show more

    Shire Company Life and Culture

    You may also be interested in